United Kingdom · Series A startup

Who invested in Apertura Gene Therapy

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$67Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $67MApr 2022
Investors
1
See who backed them

The rounds

  1. Apr 2022
    Series A$67M

    Source recorded

Everyone who backed them

DeerfieldVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Apertura Gene Therapy

Who invested in Apertura Gene Therapy?

Apertura Gene Therapy's investors include Deerfield.

How much has Apertura Gene Therapy raised?

Apertura Gene Therapy has raised $67M across 1 round since 2022.

When did Apertura Gene Therapy last raise?

Apertura Gene Therapy's most recent round was a Series A of $67M in Apr 2022.

What was Apertura Gene Therapy's biggest round?

Its most recent round, $67M in Apr 2022, is also its largest on record.

Who backed Apertura Gene Therapy first?

Apertura Gene Therapy's first round on record, in Apr 2022, was backed by Deerfield.

What stage is Apertura Gene Therapy at?

Apertura Gene Therapy's latest named round is a Series A, in Apr 2022.

Where is Apertura Gene Therapy based?

Apertura Gene Therapy is based in the United Kingdom.

Companies like Apertura Gene Therapy

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.